GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Ossiam

Ossiam grew its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 9,036.9% during the 4th quarter, HoldingsChannel.com reports. The firm owned 70,080 shares of the company’s stock after buying an additional 69,313 shares during the quarter. Ossiam’s holdings in GE HealthCare Technologies were worth $5,479,000 as of its most recent filing with the SEC.

Several other institutional investors also recently added to or reduced their stakes in the company. Morse Asset Management Inc acquired a new stake in shares of GE HealthCare Technologies during the third quarter worth about $613,000. Diamant Asset Management Inc. boosted its holdings in GE HealthCare Technologies by 4.2% during the third quarter. Diamant Asset Management Inc. now owns 10,257 shares of the company’s stock worth $963,000 after buying an additional 410 shares in the last quarter. World Investment Advisors LLC increased its stake in GE HealthCare Technologies by 44.5% in the 3rd quarter. World Investment Advisors LLC now owns 4,716 shares of the company’s stock valued at $443,000 after purchasing an additional 1,453 shares in the last quarter. Wilmington Savings Fund Society FSB boosted its position in shares of GE HealthCare Technologies by 150.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 11,278 shares of the company’s stock worth $1,058,000 after buying an additional 6,770 shares in the last quarter. Finally, Tidal Investments LLC lifted its holdings in shares of GE HealthCare Technologies by 32.5% in the third quarter. Tidal Investments LLC now owns 23,715 shares of the company’s stock valued at $2,226,000 after purchasing an additional 5,819 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on GEHC shares. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and increased their price objective for the company from $85.00 to $100.00 in a research note on Tuesday, March 11th. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an “overweight” rating in a report on Friday, February 14th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their target price for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. Citigroup boosted their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research note on Thursday, February 13th. Finally, BTIG Research set a $95.00 price target on GE HealthCare Technologies and gave the company a “buy” rating in a research report on Monday, April 14th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $97.27.

GE HealthCare Technologies Stock Up 1.4 %

Shares of NASDAQ:GEHC opened at $62.37 on Friday. GE HealthCare Technologies Inc. has a 52-week low of $57.65 and a 52-week high of $94.80. The company has a market capitalization of $28.56 billion, a price-to-earnings ratio of 14.40, a price-to-earnings-growth ratio of 3.19 and a beta of 1.14. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The company has a 50 day moving average of $79.26 and a two-hundred day moving average of $83.03.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be given a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.22%. The ex-dividend date of this dividend is Friday, April 25th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.